Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Karina Dahl Steffensen; Rikke Fredslund Andersen; Anders Jakobsen

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Karina Dahl Steffensen, Rikke Fredslund Andersen, Anders Jakobsen

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Originalsprog	Dansk
Publikationsdato	4. jun. 2018
Status	Udgivet - 4. jun. 2018
Begivenhed	2018 ASCO Annual Meeting: Delivering discoveries: Expanding the reach of precision medicine - McCormick Place, Chicago , USA Varighed: 1. jun. 2018 → 5. jun. 2018 https://am.asco.org

Konference

Konference	2018 ASCO Annual Meeting
Lokation	McCormick Place
Land	USA
By	Chicago
Periode	01/06/2018 → 05/06/2018
Internetadresse	https://am.asco.org

Bibliografisk note

J Clin Oncol 36, 2018 (suppl; abstr 5540)

Dokumenter og links

https://meetinglibrary.asco.org/record/163523/abstract

Methyleret gen afslører effekt af PARP-hæmmere
Karina Dahl Steffensen
06/06/2018
1 element af Mediedækning
Presse/medie

Citationsformater

@conference{9ec1de1aad954fada775ecca16b33e8b,

title = "Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.",

author = "{Dahl Steffensen}, Karina and {Fredslund Andersen}, Rikke and Anders Jakobsen",

note = "J Clin Oncol 36, 2018 (suppl; abstr 5540); 2018 ASCO Annual Meeting : Delivering discoveries: Expanding the reach of precision medicine ; Conference date: 01-06-2018 Through 05-06-2018",

year = "2018",

month = jun,

day = "4",

language = "Dansk",

url = "https://am.asco.org",

}

TY - CONF

T1 - Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

AU - Dahl Steffensen, Karina

AU - Fredslund Andersen, Rikke

AU - Jakobsen, Anders

N1 - J Clin Oncol 36, 2018 (suppl; abstr 5540)

PY - 2018/6/4

Y1 - 2018/6/4

M3 - Poster

T2 - 2018 ASCO Annual Meeting

Y2 - 1 June 2018 through 5 June 2018

ER -

Methylated circulating tumor DNA as a potential marker of PARP inhibitor efficiency in BRCA mutated ovarian cancer patients.

Konference

Bibliografisk note

Dokumenter og links

Methyleret gen afslører effekt af PARP-hæmmere

Citationsformater